Tiziana Life Sciences Faces Nasdaq Delisting Warning
Ticker: TLSA · Form: 6-K · Filed: Jan 31, 2025 · CIK: 1723069
Sentiment: bearish
Topics: listing-compliance, delisting-risk, nasdaq
Related Tickers: TLSA
TL;DR
Nasdaq warning for Tiziana Life Sciences: bid price below $1.00, 180 days to fix or get booted.
AI Summary
On January 29, 2025, Tiziana Life Sciences Ltd received a notice from Nasdaq stating it is not in compliance with the $1.00 Minimum Bid Price Requirement for continued listing. The company has a 180-day period to regain compliance.
Why It Matters
Failure to meet the minimum bid price could lead to the company's shares being delisted from Nasdaq, impacting liquidity and investor confidence.
Risk Assessment
Risk Level: medium — The company faces a delisting risk if it cannot meet the minimum bid price requirement within the specified timeframe.
Key Numbers
- $1.00 — Minimum Bid Price (The threshold Tiziana Life Sciences must maintain for Nasdaq listing.)
Key Players & Entities
- Tiziana Life Sciences Ltd (company) — The company that received the notice
- Nasdaq Stock Market LLC (company) — The exchange that issued the non-compliance notice
- $1.00 (dollar_amount) — The minimum bid price requirement
- January 29, 2025 (date) — Date the notice was received
- 180-day period (duration) — The compliance period granted
FAQ
What is the specific reason Tiziana Life Sciences received a notice from Nasdaq?
Tiziana Life Sciences received a notice because it is not currently in compliance with the $1.00 Minimum Bid Price Requirement for continued listing on Nasdaq.
When did Tiziana Life Sciences receive this notice?
The company received the notice on January 29, 2025.
What is the timeframe given to Tiziana Life Sciences to regain compliance?
The company has a 180-day period to regain compliance with the Minimum Bid Price Requirement.
What is the consequence if Tiziana Life Sciences fails to regain compliance?
Failure to regain compliance could result in the company not meeting the requirements for continued listing on Nasdaq.
What is the exact name of the company filing this report?
The exact name of the company is Tiziana Life Sciences LTD.
Filing Stats: 372 words · 1 min read · ~1 pages · Grade level 15.9 · Accepted 2025-01-31 17:25:02
Key Financial Figures
- $1.00 M — is not currently in compliance with the $1.00 Minimum Bid Price Requirement for continu
- $1.00 — s ordinary share’s meet or exceed $1.00 per ordinary share for at least ten con
Filing Documents
- ea0229454-6k_tiziana.htm (6-K) — 13KB
- 0001213900-25-008957.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TIZIANA LIFE SCIENCES LTD Date: January 31, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 2